EL.En. S.p.A. (BIT:ELN)
Italy · Delayed Price · Currency is EUR 12.19
0.00 (0.00%)
At close: Mar 27, 2026
EL.En. Revenue
In the year 2025, EL.En. had annual revenue of 590.85M EUR with 4.42% growth.
Revenue
590.85M
Revenue Growth
+4.42%
P/S Ratio
1.65
Revenue / Employee
284.06K
Employees
1,420
Market Cap
975.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 590.85M | 25.00M | 4.42% |
| Dec 31, 2024 | 565.85M | -10.17M | -1.76% |
| Dec 31, 2023 | 576.01M | -97.57M | -14.49% |
| Dec 31, 2022 | 673.58M | 102.18M | 17.88% |
| Dec 31, 2021 | 571.40M | 163.32M | 40.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| Safilo Group | 983.38M |
| GPI S.p.A. | 531.42M |
| Garofalo Health Care | 487.08M |
| Svas Biosana | 134.95M |
| Pharmanutra | 133.97M |